ALIX regulates tumor-mediated immunosuppression by controlling EGFR activity and PD-L1 presentation by Monypenny, J, Milewicz, H, Flores-Borja, F, Weitsman, G, Cheung, A, Chowdhury, R, Burgoyne, T, Arulappu, A, Lawler, K, Barber, P, Vicencio, J, Keppler, M, Wulaningsih, W, Davidson, S, Fraternali, F, Woodman, N, Turmaine, M, Gillett, C, Franz, D, Quezada, S, Futter, C, Von Kriegsheim, A, Kolch, W, Vojnovic, B, Carlton, J, Ng, T